Fig. 1: Schematic representation of samples and analysis. | Oncogene

Fig. 1: Schematic representation of samples and analysis.

From: Evidence of DNA methylation heterogeneity and epipolymorphism in kidney cancer tissue samples

Fig. 1

Heterogeneity was evaluated between patients, within a patient and within a sample (A). The discovery cohort consists of multi-region samples from patients with ccRCC, with matched Epic-seq, RNA-seq and WES (B). In addition, methylation data were generated for a cohort of tumour and normal samples from patients with ccRCC (i.e. not multi-region samples) and cell lines.

Back to article page